Genetic, nongenetic and epigenetic risk determinants in developmental programming of type 2 diabetes. | Department of Endocrinology, Diabetes & Metabolism
Order Books Courses Offered
+91 416 228 2528
CMC Logo
Department of Endocrinology, Diabetes & Metabolism
Christian Medical College Vellore
Department of Endocrinology Christian Medical College Vellore
Book
Appointment
Patient
Services
Admissions
Site Map Order Books
Department of Endocrinology, Diabetes & Metabolism
Christian Medical College Vellore
Not to be ministered unto but to minister
News

The Department of Endocrinology, Christian Medical College Vellore has launched its official Endocrinology CMC Vellore Android app now available on the Google Play Store — users can download it to access the latest department updates, academic resources, event notifications, and educational materials on diabetes and endocrine care.

Genetic, nongenetic and epigenetic risk determinants in developmental programming of type 2 diabetes.

  1. Department of Endocrinology, Diabetes and Metabolism, Rigshospitalet University Hospital/Copenhagen University, Copenhagen, Denmark
  2. Department of Clinical Sciences, Lund University, Malmö, Sweden.

Acta obstetricia et gynecologica Scandinavica Vol. 93 · Issue 11 · pp. 1099-108

PMID 25179736 DOI 10.1111/aogs.12494

Cite This Article

Allan Vaag, Charlotte Brøns, Linn Gillberg, Ninna S Hansen, Line Hjort, Geeti P Arora, Nihal Thomas, Christa Broholm, Rasmus Ribel-Madsen, Louise G Grunnet. Genetic, nongenetic and epigenetic risk determinants in developmental programming of type 2 diabetes. Acta obstetricia et gynecologica Scandinavica. 2014;93(11):1099-108. doi:10.1111/aogs.12494

Abstract

Low birthweight (LBW) individuals and offspring of women with gestational diabetes mellitus (GDM) exhibit increased risk of developing type 2 diabetes (T2D) and associated cardiometabolic traits in adulthood, which for both groups may be mediated by adverse events and developmental changes in fetal life. T2D is a multifactorial disease occurring as a result of complicated interplay between genetic and both prenatal and postnatal nongenetic factors, and it remains unknown to what extent the increased risk of T2D associated with LBW or GDM in the mother may be due to, or confounded by, genetic factors. Indeed, it has been shown that genetic changes influencing risk of diabetes may also be associated with reduced fetal growth as a result of reduced insulin secretion and/or action. Similarly, increased risk of T2D among offspring could be explained by T2D susceptibility genes shared between the mother and her offspring. Epigenetic mechanisms may explain the link between factors operating in fetal life and later risk of developing T2D, but so far convincing evidence is lacking for epigenetic changes as a prime and direct cause of T2D. This review addresses recent literature on the early origins of adult disease hypothesis, with a special emphasis on the role of genetic compared with nongenetic and epigenetic risk determinants and disease mechanisms.

Keywords

  • Fetal programming
  • epigenetics
  • genetics
  • gestational diabetes
  • low birthweight
  • twins
MAKE AN APPOINTMENT
CMC Endocrinology
Add to your Home Screen for quick access

Tap the Share button in your browser

then select "Add to Home Screen"

CMC Endocrinology

CMC Endocrinology

CMC Vellore

🔔 Notifications

← Back to notifications